#fostriecin

Briefing: Why a potential anti-cancer agent stalled in trials: New enzyme insights may boost yield and purity

Strategic angle: Researchers at the University of Bayreuth have deciphered key steps in the biosynthetic mechanism of fostriecin, a potential anti-cancer agent.